INCREASED FREQUENCY OF MEFV GENES IN
PATIENTS WITH EPIGASTRIC PAIN SYNDROME
Coskun BD1, Kiraz A2, Sevinc E1, Baspinar O3, Cakmak E4
*Corresponding Author: Banu D. Coskun, M.D., Kicikapı Mahallesi Hoca Ahmet Yesevi Cad Hidayet Eraslan sitesi B Blok
No: 12, Talas/Kayseri Turkey. Tel: +90-506-323-24-86. Fax: +90-352-437-52-73. E-mail: demetcoskun2@gmail.com
page: 51
|
|
REFERENCES
1. Shaib Y, El-Serag HB. The prevelance of risk factors
of functional dyspepsia in a multiethnic population in
the United States. Am J Gastroenterol. 2004; 99(11):
2210-2216. 2. Tack J, Talley NJ, Camilleri M, Holtmann G, Hu P,
Malagelada JR, et al. Functional gastroduodenal disorders.
Gastroenterology. 2006; 130(5): 1466-1479.
3. Tack J, Talley NJ. Functional dyspepsia – symptoms,
definitions and validity of the Rome III criteria. Nat
Rev Gastroenterol Hepatol. 2013; 10(3): 134-141.
4. Moayyedi P, Soo S, Deeks J, Delaney B, Innes M,
Forman D. Pharmacological interventions for nonulcer
dyspepsia. Cochrane Database Syst Rev. 2006;
(4): CD001960. Review. Update in: Cochrane Database
Syst Rev. 2011; (2): CD001960.
5. Miwa H, Kusano M, Arisawa T, Oshima T, Kato M,
Joh T, et al. Evidence-based clinical practice guidelines
for functional dyspepsia. J Gastroenterol. 2015;
50(2): 125-139.
6. Junk HK, Keum BR, Jo YJ, Jee SR, Rhee PL, Kang
YW. Diagnosis of functional dyspepsia: A systematic
review. Korean J Gastroenterol. 2010; 55(5): 296-307.
7. Padeh S, Berkun Y. Auto-inflammatory fever syndromes.
Rheum Dis Clin North Am. 2007; 33(3):
585-623.
8. The French FMF Consortium. A candidate gene for
familial Mediterranean fever. Nat Genet. 1997; 17(1):
25-31.
9. Soriano A, Manna R. Familial Mediterranean fever:
New phenotypes. Autoimmun Rev. 2012; 12(1): 31-37.
10. Grateau G, Pêcheux C, Cazeneuve C, Cattan D,
Dervichian M, Goossens M, et al. Clinical versus
genetic diagnosis of familial Mediterranean fever.
QJM. 2000; 93(4): 223-229.
11. INFEVERS. The registry of Familial Mediterranean
Fever (FMF) and heriditary autoinflammatory disorders
mutations (http://fmf.igh.cnrs.fr.ISSAID/infevers).
12. Livneh A, Langevitz P, Zemer D, Zaks N, Kees S,
Lidar T, et al. Criteria for the diagnosis of familial
Mediterranean fever. Arthritis Rheum. 1997; 40(10):
1879-1885.
13. Marek-Yagel D, Berkun Y, Padeh S, Abu A, Reznik-
Wolf H, Livneh A, et al. Clinical disease among patients
heterozygous for familial Mediterranean fever.
Arthritis Rheum. 2009; 60(6): 1862-1866.
14. Padeh S, Shinar Y, Pras E, Zemer D, Langevitz P,
Pras M, et al. Clinical and diagnostic value of genetic
testing in 216 Israeli children with Familial Mediterranean
fever. J Rheumatol. 2003; 30(1): 185-190.
15. Touitou I. Inheritance of autoinflammatory diseases:
Shifting paradigms and nomenclature. J Med Genet.
2013; 50(6): 349-359.
16. Etem EO, Deveci SD, Erol D, Yuce H, Elyas H. Familial
Mediterranean Fever: A retrospective clinical
and molecular study in the east of Anatolia region of
Turkey. Open Rheumatol J. 2010; 4: 1-6.
17. Sarkisian T, Ajrapetian H, Beglarian A, Shahsuvarian
G, Egiazarian A. Familial Mediterranean fever
in Armenian population. Georgian Med News. 2008;
156: 105-111.
18. Sharkia R, Mahajnah M, Zalan, Sourlis C, Bauer P,
Schöls L. Comparative screening of FMF mutations
in various communities of the Israeli society. Eur J
Med Genet. 2013; 56(7): 351-355.
19. Erden G, Bal C, Gungor Torun O, Uguz, Yıldırımkaya
M. Evaluating the frequency of MEFV gene in a group
of patients with pre-diagnosis of Familial Mediterranean
Fever. Turk Hij Tecr Biyol Derg. 2008; 65(1): 1-5.
20. Ozcakar ZB, Yalcınkaya F, Cakar N, Acar B, Bilgiç
AE, Uncu N, et al. Application of the new pediatric
criteria and Tel Hashomer criteria in heterozygous
patients with clinical features of FMF. Eur J Pediatr.
2011; 170(8): 1055-1057.
21. Akin H, Onay H, Turker E, Cogulu O, Ozkınay F.
MEFV mutations in patients with Familial Mediterranean
Fever from the Aegean region of Turkey. Mol
Biol Rep. 2010; 37(1): 93-98.
22. Gülec D, Sirin Y, Kocaöz S, Uzuncan N, Pirim I. The
clinical
significance of R202Q mutation in the pyrin
gene. Turkiye Klinikleri J Med Sci. 2015; 35(2): 106-
111.
23. Ozturk A, Ozcakar B, Ekim M, Akar N. Is MEFV
gene Arg202Gln (605 G>A) a disease-causing mutation?
Turk J Med Sci. 2008; 38(3): 205-208.
24. Yigit S, Karakus N, Tasliyurt T, Kaya SU, Bozkurt
N, Kisacik B. Significance of MEFV gene R202Q
polymorphism in Turkish familial Mediterranean
fever patients. Gene. 2012; 506(1): 43-45.
25. Giaglis S, Papadopoulos V, Kambas K, Doumas
M, Tsironidou V, Rafail S, et al. MEFV alterations
and population genetics analysis in a large cohort of
Greek patients with familial Mediterranean fever.
Clin Genet. 2007; 71(5): 458-467.
26. Comak E, Akman S, Koyun M, Dogan CS, Gokceoglu
AU, Arikan Y, et al. Clinical evaluation of R202Q
alteration of MEFV genes in Turkish children. Clin
Rheumatol. 2014; 33(12): 1765-1771.
27. Cankaya T, Bora E, Bayram Torun M, Ulgenalp A, Kavukçu S, Türkmen A, et al. Clinical significance
of R202Q alteration of MEFV gene in children with
Familial Mediterranean fever. Arch Rheumatol. 2015;
30(1): 51-56.
28. Yilmaz E, Ozen S, Balci B, Duzova A, Topaloglu
R, Besbas N, et al. Mutation frequency of Familial
Mediterranean fever and evidence for a high carrier
rate in the Turkish population. Eur J Hum Genet.
2001; 9(7): 553-555.
29. Oztuzcu S, Ulasli M, Ergun S, Igci YZ, Igci M,
Bayraktar R, et al. Screening of common and novel
familial Mediterranean fever mutations in south-east
part of Turkey. Mol Biol Rep. 2014; 41(4): 2601-2607.
30. Salehzadeh F, Jafari M, Asl SH, Jahangiri S, Habibzadeh
S. MEFV gene profile in Northwest of Iran,
twelve common MEFV gene mutations analysis in
216 patients with Familial Mediterranean Fever. Iran
J Med Sci. 2015; 40(1): 68-72.
31. Ben-Chetrit E, Lerer I, Malamud E, Domingo C,
Abeliovich D. The E148Q mutation in the MEFV
gene: Is it a disease-causing mutation or a sequence
variant? Hum Mutat. 2000; 15(4):385-386.
32. Marek-Yagel D, Bar-Joseph I, Pras E, Berkun Y. Is
E148Q a benign polymophism or a disease-causing
mutation? J Rheumatol. 2009; 36(10): 2372.
33. Altug U, Ensari C, Sayin DB, Ensari A. MEFV gene
mutations in Henosch Schönlein purpura. Int J Rheu
Dis. 2013; 16(3): 347-351.
34. Beheshtian M, Izadi N, Kriegshauser G, Kahrizi K,
Mehr EP, Rostami M, et al. Prevalence of common
MEFV mutations and carrier frequencies in a large
cohort of Iranian populations. J Genet. 2016; 93(3):
667-674.
35. Dogan H, Faruk Bayrak O, Emet M, Keles M, Gulluoglu
S, Gul Z, et al. Familial Mediterranean fever gene
mutations in north-eastern part of Anatolia with special
respect to rare mutations. Gene. 2015; 568(2):
170-175.
36. Gunesacar R, Celik MM, Arica V, Elmacioglu S,
Ozturk OH. Frequency of MEFV gene mutations in
Hatay province, Mediterranean region of Turkey and
report of a novel missense mutation (I247V). Gene.
2014; 546(2): 195-199.
37. Albayrak F, Selcuk NY, Odabas AR, Cetinkaya R,
Pirim I. Genotype-phenotype correlation in patients
with familial Mediterranean fever in East Anatolia.
Genet Test Mol Biomarkers. 2010; 14(3): 325-328.
38. Tomiyama N, Higashiuesato Y, Oda T, Baba E, Harada
M, Azuma M, et al. MEFV mutation analysis
of familial Mediterranean fever in Japan. Clin Exp
Rheumatol. 2008; 26(1): 13-17.
39. Ozturk MA, Kanbay M, Kasapoglu B, Onat AM, Guz
G, Furst DE, et al. Therapeutic approach to familial
Mediterrenean fever: A review update. Clin Exp
Rheumatol. 2011; 29(4 Suppl 67): 77-86.
40. Camus D, Shinar Y, Aamar S, Langevitz P, Ben-Zvi
I, Livneh A, et al. ‘Silent’ carriage of two familial
Mediterranean fever gene mutations in large families
with only a single identified patient. Clin Genet. 2012;
82(3): 288-291.
|
|
|
|
 |
Number 27
VOL. 27 (2), 2024 |
Number 27
VOL. 27 (1), 2024 |
Number 26
Number 26 VOL. 26(2), 2023 All in one |
Number 26
VOL. 26(2), 2023 |
Number 26
VOL. 26, 2023 Supplement |
Number 26
VOL. 26(1), 2023 |
Number 25
VOL. 25(2), 2022 |
Number 25
VOL. 25 (1), 2022 |
Number 24
VOL. 24(2), 2021 |
Number 24
VOL. 24(1), 2021 |
Number 23
VOL. 23(2), 2020 |
Number 22
VOL. 22(2), 2019 |
Number 22
VOL. 22(1), 2019 |
Number 22
VOL. 22, 2019 Supplement |
Number 21
VOL. 21(2), 2018 |
Number 21
VOL. 21 (1), 2018 |
Number 21
VOL. 21, 2018 Supplement |
Number 20
VOL. 20 (2), 2017 |
Number 20
VOL. 20 (1), 2017 |
Number 19
VOL. 19 (2), 2016 |
Number 19
VOL. 19 (1), 2016 |
Number 18
VOL. 18 (2), 2015 |
Number 18
VOL. 18 (1), 2015 |
Number 17
VOL. 17 (2), 2014 |
Number 17
VOL. 17 (1), 2014 |
Number 16
VOL. 16 (2), 2013 |
Number 16
VOL. 16 (1), 2013 |
Number 15
VOL. 15 (2), 2012 |
Number 15
VOL. 15, 2012 Supplement |
Number 15
Vol. 15 (1), 2012 |
Number 14
14 - Vol. 14 (2), 2011 |
Number 14
The 9th Balkan Congress of Medical Genetics |
Number 14
14 - Vol. 14 (1), 2011 |
Number 13
Vol. 13 (2), 2010 |
Number 13
Vol.13 (1), 2010 |
Number 12
Vol.12 (2), 2009 |
Number 12
Vol.12 (1), 2009 |
Number 11
Vol.11 (2),2008 |
Number 11
Vol.11 (1),2008 |
Number 10
Vol.10 (2), 2007 |
Number 10
10 (1),2007 |
Number 9
1&2, 2006 |
Number 9
3&4, 2006 |
Number 8
1&2, 2005 |
Number 8
3&4, 2004 |
Number 7
1&2, 2004 |
Number 6
3&4, 2003 |
Number 6
1&2, 2003 |
Number 5
3&4, 2002 |
Number 5
1&2, 2002 |
Number 4
Vol.3 (4), 2000 |
Number 4
Vol.2 (4), 1999 |
Number 4
Vol.1 (4), 1998 |
Number 4
3&4, 2001 |
Number 4
1&2, 2001 |
Number 3
Vol.3 (3), 2000 |
Number 3
Vol.2 (3), 1999 |
Number 3
Vol.1 (3), 1998 |
Number 2
Vol.3(2), 2000 |
Number 2
Vol.1 (2), 1998 |
Number 2
Vol.2 (2), 1999 |
Number 1
Vol.3 (1), 2000 |
Number 1
Vol.2 (1), 1999 |
Number 1
Vol.1 (1), 1998 |
|
|
